Be able to safely initiate and maintain special populations on buprenorphine.
Goal: The learner will be able to safely transfer methadone patients to buprenorphine maintenance and induct and maintain other special populations on buprenorphine.
Demonstrate an understanding of special precautions required throughout the phases of buprenorphine treatment for patients on methadone and other special populations, including pregnant women, teens, elderly, patients with psychiatric comorbidities, and patients with chronic pain.
Recognize and anticipate complications of buprenorphine use and prepare to deal with occasional complications in methadone patients and other special populations
Be able to maintain patients on buprenorphine, and deal with special situations in buprenorphine treatment.
Goal: The learner will be able to maintain patients on buprenorphine, and deal with special situations in buprenorphine treatment including continued use of drugs during buprenorphine treatment, discontinuation of buprenorphine treatment, and the use of buprenorphine in medically supervised withdrawal from opioids (detoxification).
Demonstrate a thorough understanding of dosing principles to help your patients succeed throughout the maintenance phase of buprenorphine treatment.
Recognize and anticipate complications of buprenorphine use during the maintenance phase of treatment and prepare to deal with and minimize complications in your patients when discontinuing buprenorphine or using buprenorphine in medically supervised withdrawal (detoxification).
Prepare to deal with and minimize complications in your patients when discontinuing buprenorphine or using buprenorphine in medically supervised withdrawal (detoxification).
Demonstrate a thorough understanding of special situations in buprenorphine treatment: continued use of drugs while on buprenorphine, tapering off of buprenorphine, and use of buprenorphine for medically supervised withdrawal from opioids (detoxification).
This is a DATA 2000 Training Program, which is the equivalent of an 8 hour classroom experience. Full completion of the program requires that you spend an appropriate amount of time on the modules AND successfully complete the assessments.
Then you can submit your waiver request to CSAT/SAMHSA.
We can not certify your successful completion of this DATA 2000 qualifying training program if your participation does not meet or exceed the minimum standard.
Development of this website was funded entirely by grant #R44DA12066 and contract #HHSN271200655304C from the National Institute on Drug Abuse (NIDA) at the National Institutes of Health. The website contents are solely the responsibility of the authors and do not necessarily represent the official views of NIDA. Ongoing development and maintenance is funded by the training fee and Clinical Tools, Inc. No commercial support is received.
Clinical Tools, Inc. is accredited by the ACCME to provide continuing medical education for physicians.
Interactive training is delivered by the CTI Learning Ecosystem and our FAOS DLearning Drupal modules and requires IE 10/ higher, Firefox, Chrome or Safari.
Unless otherwise noted, individuals pictured are models and are used for illustrative purposes only.
developed & maintained by
A member of The Clinical Tools, Inc (CTI) Addiction Training Group: SBIRT Training | Opioid Risk Reduction | Buprenorphine Training
This site is for educational purposes only and medical decisions should not be based solely on its content. This site, its authors, and its consultants do not assume liability for errors or omissions.